Journal of the National Cancer Institute Q1 Unclaimed
Journal of the National Cancer Institute is a journal indexed in SJR in Oncology and Cancer Research with an H index of 387. Journal with a Single blind Peer Review review system, and It has a price of 3578 €. The scope of the journal is focused on Cancer, Medicine. It has an SJR impact factor of 4,986 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 4,986.
Journal of the National Cancer Institute focuses its scope in these topics and keywords: cancer, breast, prostate, clinical, bite, lung, controlled, receptor, risk, group, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -
3578 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
4,986
SJR Impact factor387
H Index211
Total Docs (Last Year)719
Total Docs (3 years)2601
Total Refs4647
Total Cites (3 years)510
Citable Docs (3 years)6.6
Cites/Doc (2 years)12.33
Ref/DocOther journals with similar parameters
Molecular Cancer Q1
Journal of Thoracic Oncology Q1
JAMA oncology Q1
Cancer Discovery Q1
Journal of Hematology and Oncology Q1
Compare this journals
Aims and Scope
Best articles by citations
For Telomeres, Longer Is Not Always Better
View moreRelationship of Leukemia Risk to Radiation Dose Following Cancer of the Uterine Corpus
View moreHelicobacter pylori Seroprevalence and Colorectal Neoplasia: Evidence Against an Association
View moreChromosomal Abnormalities in Patients With Hodgkin's Disease: Evidence for Frequent Involvement of the 14q Chromosomal Region but Infrequent bcl-2 Gene Rearrangement in Reed-Sternberg Cells
View moreRisk of Transfusion-Associated Transmission of Human Herpesvirus 8
View moreIn Different Cultures, Cancer Screening Presents Challenges
View moreEvaluation of Bias in Familial Risk Estimates: A Study of Common Cancers Using Swedish Population-based Registers
View moreGender- and Smoking-Related Bladder Cancer Risk
View moreProstate Cancer Screening at National Cancer Institute Comprehensive and Clinical Cancer Centers
View morePsychosocial Care Integral for Breast Cancer Patients, Report Concludes
View moreProtein N-Myristoylation as a Chemotherapeutic Target for Cancer
View moreFor Whom the Bell Tolls: Susceptibility to Common Adult Cancers in Retinoblastoma Survivors
View moreCommon Threads of Mucosa-Associated Lymphoid Tissue Lymphoma Pathogenesis: From Infection to Translocation
View moreBrief Communication: B-Cell Origin of Hamster Lymphoid Tumors Induced by Simian Virus 40
View moreBurkitt's Lymphoma in the Mengo Districts of Uganda: Epidemiologic Features and Their Relationship to Malaria
View moreSuppression of Metastasis--A New Function for Known Proteins
View moreNorwegian Law Brings Alternative Medicine to the Mainstream
View moreAs Targeted Therapies Evolve, Challenges Remain
View moreXenografts Raise Questions About Cancer Virus Transfer to Humans
View moreHodgkin Lymphoma: Current Status and Clinical Trial Recommendations
View moreMale Breast Cancer During Finasteride Therapy
View morePress Release: Active Smoking Associated With Increased Risk of Breast Cancer
View moreFunding Cuts for Public Health Projects in Europe May Affect International Cancer Effort
View morePress Release: Aspirin Use May Be Associated With Increased Risk of Pancreatic Cancer
View more
Comments